Journals / Eurasian Journal of Veterinary Sciences / 2010 / Cilt: 26 - Sayı: 1

Endotoksemide ilaçların sitokinler, adenozin deaminaz ve 13,14-dihidro-15-keto-prostaglandin $F_{2alpha}$'nın kinetik değerlerine etkisi: Farklı bir yaklaşım

Effects of drugs on kinetic values of cytokines, adenosine deaminase and 13,14-dihydro-15-keto-prostaglandin $F_{2alpha}$ in endotoxemia: A different approach

Pages
15–19
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: ENR increased (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Altan F, Elmas M, Er A, Uney K, Cetin G, Tras B, Yazar E.
📊
Key Findings & Data:Effects of drugs on kinetic values of cytokines, adenosine deaminase and 13,14-dihydro-15-keto-prostaglandin F2a in endotoxemia: A different approach.
💡
Conclusion & Impact:Results: ENR increased (p
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Altan F, Elmas M, Er A, Uney K, Cetin G, Tras B, Yazar E. Effects of drugs on kinetic values of cytokines, adenosine deaminase and 13,14-dihydro-15-keto-prostaglandin F2a in endotoxemia: A different approach. Eurasian J Vet Sci, 2010, 26, 1, 15-19 Aim: The objective of this study was to determine the effects of enrofloxacin (ENR), flunixin meglumine (FM) and dexamethasone (DEX) on kinetic values of cytokines, adenosine deaminase (ADA) and 13,14-dihydro-15-keto-prostaglandin F2a (PGM) in lipopolysaccharide-induced endotoxemia. Materials and Methods: Rats were divided into seven groups. To induce endotoxemia, lipopolysaccharide (LPS) was injected into all groups, including the positive control. The six other groups received the following drugs: ENR, FM, low-dose DEX, high-dose DEX, ENR + FM + low-dose DEX and ENR + FM + high-dose DEX. After the treatments, blood samples were collected at 0, 1, 2, 4, 6, 8, 12, 24, and 48 hours. Serum tumor necrosis factor alpha ($TNF_{alpha}$), interleukin- 6 (IL-6), interleukin-10 (IL-10), ADA and plasma PGM levels were determined by ELISA. Area under the concentration time curve ($AUC_{0-48}$), maximal concentration in plasma or serum ($C_{max}$) and time to reach ($t_{max}$) values were determined by pharmacokinetic computer program. Results: ENR increased (p

Özet

Altan F, Elmas M, Er A, Üney K, Çetin G, Traş B, Yazar E. Endotoksemide ilaçların sitokinler, adenozin deaminaz ve 13,14-dihidro-15-keto-prostaglandin F_{2alpha'nın kinetik değerlerine etkisi: Farklı bir yaklaşım. Eurasian J Vet Sci, 2010, 26, 1, 15-19 Amaç: Lipopolisakkaritle (LPS) oluşturulan deneysel endotoksemide sitokinler, adenozin deaminaz (ADA) ve 13,14-dihidro-15-keto-prostaglandin $F_{2alpha}$ (PGM)’nın kinetik değerlerine tek başlarına ve/veya kombine uygulanan enrofloksasin (ENR), fluniksin meglumin (FM) ve deksametazonun (DEX) etkilerini belirlemektir. Gereç ve Yöntem: Araştırmada kullanılan ratlar 7 gruba ayrıldı. Deneysel endotoksemi oluşturmak için pozitif kontrol grubu dahil bütün gruplara LPS uygulandı. Diğer altı gruba ENR, FM, düşük doz DEX, yüksek doz DEX, ENR+FM+düşük doz DEX ve ENR+FM+yüksek doz DEX uygulandı. Uygulama sonrası 0, 1, 2, 4, 6, 8, 12, 24 ve 48. saatlerde kan örnekleri toplandı. Tümör nekroz faktör alfa ($TNF_{alpha}$), interlökin-6 (IL- 6), interlökin-10 (IL-10), ADA ve PGM düzeyleri ELISA ile belirlendi. Eğri altında kalan alan ($EAA_{0-48}$) farmakokinetik programla, plazma veya serum maksimum konsantrasyon ($C_{max}$) ile maksimum konsantrasyona ulaşma zamanı ($t_{max}$) direk bakı yöntemiyle belirlendi. Bulgular: Pozitif kontrol (LPS) grubuyla kıyaslandığında $EAA_{0-48}$ değerlerinin; ENR grubunda PGM için artarken (p

🔖

Cite This Article

ELMAS, M., ER, A., ALTAN, F., TRAS, B., UNEY, K., Gul, Ç., YAZAR, E. (2022). Endotoksemide ilaçların sitokinler, adenozin deaminaz ve 13,14-dihidro-15-keto-prostaglandin $F_{2alpha}$'nın kinetik değerlerine etkisi: Farklı bir yaklaşım. Eurasian Journal of Veterinary Sciences, Cilt: 26 - Sayı: 1, 15–19. https://ajindex.com/articles/510192

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Aldridge AJ, 2002. Pole of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur J Surg, 168, 204-214.
  2. Andreasen AS, Krabbe KS, Krogh-Madsen R, Taudorf S, Pedersen BK, Moller K, 2008. Human endotoxemia as a model of systemic inflammation. Curr Med Chem, 15, 1697-1705.
  3. Basu S, Eriksson M, 2000. Vitamin E in relation to lipid peroxidation in experimental septic shock. Prostag Leukotr Ess, 62, 195-199.
  4. Basu S, Nozari A, Liu XL, Rubertsson S, Wiklund L, 2000. Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest. FEBS Letters, 470, 1-6.
  5. Chatterjee S, Premachandran S, Shukla J, Poduval TB, 2007. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide induced septic shock. J Surg Res, 140, 99-108.
  6. Conlon BA, Law WR, 2004. Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory response. Clin Exp Immunol, 138, 14-20.
  7. Dalhoff A, Shalit I, 2003. Immunomodulatory effects of quinolones. Lancet Infect Dis, 3, 359-371.
  8. Elmas M, Yazar E, Baş AL, Traş B, Bayezit M, Yapar K, 2002. Comparative pharmacokinetics of enrofloxacin and tissue concentrations of parent drug and ciprofloxacin after intramuscular administrations of free and liposome-encapsulated enrofloxacin in rabbits. J Vet Med B, 49,507-512.
  9. Elmas M, Uney K, Karabacak A, Yazar E, 2005. Pharmacokinetics of flunixin meglumin following intravenous administration in Angora rabbits. Bull Vet Inst Pulawy, 49, 85-89.
  10. Elmas M, Yazar E, Uney K, Er (Karabacak) A, 2006a. Influence of Escherichia coli endotoxin induced endotoxaemia on the pharmacokinetics on enrofloxacin after intravenous administration in rabbits. J Vet Med A, 53, 410-414.
  11. Elmas E, Yazar E, Uney K, Karabacak A, 2006b. Pharmacokinetics of flunixin after intravenous administration in healthy and endotoxaemic rabbits. Vet Res Commun, 30, 73-81.
  12. Elmas M, Uney K, Yazar E, Karabacak A, Tras B, 2007. Pharmacokinetics of enrofloxacin following intravenous and intramuscular administration in Angora rabbits. Res Vet Sci, 82, 242-245.
  13. Elmas M, Yazar E, Uney K, Er (Karabacak) A, Tras B, 2008. Pharmacokinetics of enrofloxacin and flunixin meglumine and interactions between both drugs after intravenous co-administration in healthy and endotoxaemic rabbits. Vet J, 177, 418-424.
  14. Elmas M, Bulbul A, Avci GE, Er A, Uney K, Yazar E, Tras B, 2009. Effects of enrofloxacin, flunixin meglumine and dexamethasone on disseminated intravascular coagulation